33332-53-5

Upstream product

• 627-42-9 2-chloroethyl methyl ether 
• 120-80-9 benzene-1,2-diol 
• 6482-24-2 2-Bromoethyl methyl ether 

Downstream Products

• 33311-30-7 1,2-bis (2-methoxyethoxy)-4-nitrobenzene 
• 344438-55-7 4,5-bis(2-methoxyethoxy)benzene-1,2-diamine 
• 33332-63-7 1,2-bis(2-methoxyethoxy)-4,5-dinitrobenzene 

Relevant academic research and scientific papers

Poly(oxyethylene)-substituted copper and lutetium phthalocyanines

A new family of nonionic water-soluble lutetium bisphthalocyanines and a copper monophthalocyanine have been synthesized and characterized. Optical absorption determinations demonstrate aggregation processes in water. Optical microscopy, differential scanning calorimetry (DSC), and X-ray diffraction measurements have also been performed on the materials. The substituted copper complex yields a hexagonal columnar liquid crystal above 62°C; this mesophase can incorporate up to 16% (w/w) of triethylene glycol without significant disturbance of the structure. One of the substituted lutetium bisphthalocyanines affords a tetragonal columnar mesophase; the other bisphthalocyanine derivatives show only highly ordered crystalline-like phases. Conductivity measurements have been carried out on thin films of the previous derivatives to determine the relative electronic and ionic conduction contributions.

Rectification in nanoscale devices based on an asymmetric five-coordinate iron(III) phenolate complex

One-way street: An asymmetric iron(III) phenolate complex with amphiphilic and redox properties was used in the formation of Langmuir-Blodgett (LB) films. These were used as a basis for nanoscale Au|LB film|Au devices that are capable of current rectifica

Fingolimod derivatives containing crown ether and bis (2 - methoxyethoxy) structure (by machine translation)

The invention synthesizes a series of fingolimod derivatives containing crown ether or bis (2 - methoxyethoxy) structure by modifying the structure of the immunosuppressant fingolimod for treating multiple sclerosis in the market. The hypoglycemic effect of the target compound was evaluated by in vivo animal experiments. The results show that the compounds including 1c - 1e, Ic-Ie have a certain effect of reducing blood sugar and have application prospects in the preparation of medicines for treating diabetes. (by machine translation)

Pyrocatechol ethers

Compounds of the formula: STR1 are disclosed which compound are used to prepare carbamates which are stated to have utility as plant protecting agents and insecticides.